Filings, Offerings and Pricings
Filings:
- YRC Worldwide (YRCW) filed for a ~20.61 mln share common stock offering by selling stockholders which includes ~17.727 mln shares of our Common Stock issued to the selling stockholders hereunder pursuant to the Transactions as described below, and ~2.333 mln shares of our Common Stock to be issued upon the conversion of our Class A Convertible Preferred Stock, par value $1.00/share.
- Arrowhead Research (ARWR) files for $200 mln mixed securities shelf offering.
- Idera Pharma (IDRA) announced that it intends to offer and sell shares of its common stock and pre-funded warrants to purchase shares of its common stock in an underwritten public offering.
- HCI Group (HCI) to cancel Series A Preferred Stock conversion rights.
- NRG Yield (NYLD) announced offering of $300 mln in aggregate principal amount of its convertible senior notes due 2019.
- Athlon Energy (ATHL) announced a public offering of 12 mln shares of common stock by selling stockholders.
- Agenus (AGEN) has commenced an underwritten public offering of shares of its common stock.
- Halozyme Therapeutics (HALO 13.78) priced ~7.692 mln shares of common stock at $13.00/share.
- Cepheid (CPHD 49.13) upsized offering by $50 mln and priced $300 mln of 1.25% Convertible Senior Notes due 2021.
- Epizyme (EPZM 30.00) priced its underwritten public offering of ~4.492 mln shares of its common stock at a price of $29.25/share before underwriting discounts; EPZM is selling 3 mln shares of its common stock in this offering, and certain existing stockholders are selling ~1.492 mln shares